Drugmaker Eli Lilly says its daily oral GLP-1 pill may help people who have obesity and people with Type 2 diabetes lose ...

(Reuters) -Eli Lilly said on Tuesday its experimental GLP-1 pill helped overweight adults with type 2 diabetes shed 10.5% of ...

New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes ...

The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to ...

After Eli Lilly’s phase 3 data drop for its oral GLP-1 asset orforglipron earlier this month, the Indianapolis drugmaker has unveiled the second half of the data package that will support the med’s | ...

KIDS as young as ten are being given weight-loss jabs on the NHS, figures suggest. At least 188 severely obese youngsters are ...

“Most users tolerate GLP-1 medications like Ozempic without serious oral health issues, but a subset experience notable side ...

FAT jabs have turned the tide on the obesity epidemic, but there’s a new challenge on the horizon – an obesity bounceback.

As Ozempic pushes food companies to reformulate their products, scientists have developed fat-trapping plant-based microbeads ...

As GLP-1 adoption grows and new applications for the drugs come to light, experts say that could have sweeping impacts for ...

A pro tennis star just 'challenged' Serena Williams to come back from her unofficial retirement and get back in the game.

After years of training at the highest level, Serena Williams choosing a GLP-1 isn’t taking the “easy” way out—it’s doing what’s best for her body now.